Atra investor alert: levi & korsinsky, llp reminds investors of an investigation involving possible securities fraud violations by certain officers and directors of atara biotherapeutics, inc.

New york, new york--(newsfile corp. - july 27, 2022) - levi & korsinsky notifies investors that it has commenced an investigation of atara biotherapeutics, inc. ("atara" or the "company") (nasdaq: atra) concerning possible violations of federal securities laws. on november 4, 2021, atara issued a press release touting its t cell immunotherapy product candidate, ata188.
ATRA Ratings Summary
ATRA Quant Ranking